BioSpace News Archive

Pharm Country

PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8 , at 7:30 a.m. PST / 10:30 a.m. EST.

January 3, 2024
·
1 min read
Business

QIAGEN expands business in Middle East with new regional headquarters and major projects

QIAGEN announced a significant expansion of its business in the Middle East region, which includes three major developments.

January 3, 2024
·
7 min read
Genetown

Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Faron Pharmaceuticals Oy announces that Dr. Markku Jalkanen, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday January 11, 2024, at 12pm PT, in San Francisco.

January 3, 2024
·
1 min read
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced positive top-line results from a confirmatory clinical study for AVT06, Alvotech’s proposed biosimilar to Eylea®.

January 3, 2024
·
8 min read
Drug Development

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma, a clinical stage oncology company, announced that the U.S. Food and Drug Administration has cleared an investigational new drug application for OBI-992, to conduct a Phase 1/2 study of its novel antibody - drug conjugate cancer therapy targeting TROP2.

January 3, 2024
·
3 min read
Genetown

Alzheon CEO Dr. Martin Tolar Awarded Eliška and Zdeněk Strmiska Award from Alzheimer’s Foundation for Significant Contribution Towards Research and Treatment of Alzheimer’s Disease, and Donated Cash Prize to INDRC Institute

Alzheon, Inc. announced that its Founder, President & CEO Dr. Martin Tolar has been awarded the Eliška and Zdeněk Strmiska Award from the Alzheimer’s Foundation for significant contribution towards the research and treatment of Alzheimer’s disease.

January 3, 2024
·
10 min read
Biotech Bay

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 11:15 a.m. PST in San Francisco.

January 3, 2024
·
1 min read
Biotech Bay

Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 11:30 a.m. PT.

January 3, 2024
·
1 min read
Business

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

InspireMD announced the appointment of medical technology executive Pete Ligotti as Executive Vice President and General Manager of North America.

January 3, 2024
·
7 min read
Drug Development

Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024

Chemomab Therapeutics Ltd. announced early completion of patient enrollment in its Phase 2 clinical trial assessing CM-101 as a treatment for primary sclerosing cholangitis.

January 3, 2024
·
7 min read